A Review on Hingwadi Churna: An Ayurvedic Compound Formulation for Ischemic Heart Disease

Abstract

Hingwadi churna, described in Charaka Samhita Siddhisthana, is indicated for disorders of Hridaya (heart). The formulation contains Hingu, Amlavetas, Shunthi, Sauvarchala lavana and Dadima as ingredients. According to Acharya Sushruta, in the presence of etiological factors, the Dosha get vitiated, undergo Sthanasamshraya in the Hridaya, and afflicts the Rasadhatu to produce pain in the cardiac region referred to as Hridbadha or Hridroga. In the contemporary medical science, these painful cardiac conditions can be correlated with ischemic heart disease. However, limited scientific literature is available regarding the role of this formulation in ischemic heart disease. The present review aims to analyse the pharmacological properties of the compound formulation and its ingredients from both Ayurvedic and contemporary scientific perspectives. Classical Ayurvedic texts and various Nighantu were reviewed along with modern scientific literature describing chemical constituents and pharmacological activities retrieved from databases such as PubMed, Google Scholar, ScienceDirect, and WHO publications. The reviewed data suggest that the ingredients of the formulation possess Deepana, Pachana, Hridya, Kapha-Vata shamana, Anulomana and Srotoshodhana properties according to Ayurvedic principles. From a contemporary biomedical viewpoint, many of the ingredients exhibit antioxidant, antihyperlipidemic, anti-inflammatory, and anti-atherosclerotic activities. These pharmacological properties suggest that Hingwadi churna has significant potential in maintaining cardiovascular health and may play a supportive role in the management of Hridroga, particularly in conditions related to ischemic heart disease.